Selskabets formål er at drive handel og produktion og anden i forbindelse hermed stående virksomhed
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 1.1 mia. | 11.7 mia. | 1.7 mia. | 398.1 mio. | 288 | |
CVR: 16210714
Secondary names: PHARMACEUTICAL RUBBER CO. ApS, SCHIØNNING & ARVE ApS, SCHUBERT SEALS ApS
Previous names: SCHUBERT SEALS A/S, THE WEST COMPANY, DANMARK A/S, WEST PHARMACEUTICAL SERVICES DANMARK A/S
1 properties
Upgrade to Pro to see addresses, building data and ownership details
Finn Kämpf Hansen left as director
Wai Wing Helen Chan joined the board
Shay Kearns joined the board
Kimberly Banks MacKay left the board
Shay Kearns left the board
Compared to 10 companies in Fremstilling af letmetalemballage
Comparison is based on industry median values
The financial health of WEST PHARMACEUTICAL SERVICES DANMARK ApS appears robust, with a significant increase in profitability in 2024, reporting a profit of 11.75 billion DKK alongside a revenue of 1.13 billion DKK. Revenue has shown a consistent upward trend, growing from 618.39 million DKK in 2020 to 1.13 billion DKK in 2024, while profit surged dramatically from 73.99 million DKK in 2023 to 11.75 billion DKK in 2024, indicating strong operational efficiency and possibly one-time gains. The equity position has decreased from over 1 billion DKK in 2023 to 398.15 million DKK in 2024, which raises concerns about financial stability despite the impressive profit margins. Overall, the company is well-positioned within the lightweight metal packaging industry, benefiting from a growing market demand.
AI-generated summary
companydata.dk